Compare OGN & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | AI |
|---|---|---|
| Founded | 1923 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | N/A | 2020 |
| Metric | OGN | AI |
|---|---|---|
| Price | $7.88 | $11.57 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 14 |
| Target Price | $14.10 | ★ $20.00 |
| AVG Volume (30 Days) | 6.2M | ★ 7.8M |
| Earning Date | 02-12-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $6,301,000,000.00 | $352,913,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.36 |
| P/E Ratio | $4.14 | ★ N/A |
| Revenue Growth | N/A | ★ 1.84 |
| 52 Week Low | $6.18 | $9.99 |
| 52 Week High | $17.23 | $35.98 |
| Indicator | OGN | AI |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 42.23 |
| Support Level | $7.74 | $9.99 |
| Resistance Level | $8.48 | $11.13 |
| Average True Range (ATR) | 0.42 | 0.79 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 6.59 | 36.82 |
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.